ERAP1 and neoplasm: Recently, the lack of ERAP1 expression in tumor cells was suggested to correlate with an enhanced ability of NK cells to efficiently kill ERAP1 deficient tumor cells, possibly due to lack of regulatory MHC class I/Ly49C interactions [16], [17].